As of Feb 24
| +0.19 / +0.45%|
The 25 analysts offering 12-month price forecasts for Sanofi have a median target of 45.50, with a high estimate of 53.89 and a low estimate of 37.44. The median estimate represents a +6.57% increase from the last price of 42.70.
The current consensus among 27 polled investment analysts is to Hold stock in Sanofi. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.